*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Pemetrexed Impurity 4 is a critical synthetic intermediate and reference standard for the pharmaceutical manufacturing of pemetrexed disodium. It is primarily generated during the <strong>multi-step organic synthesis</strong> or degradation pathways of the active pharmaceutical ingredient (API). The compound serves as an essential tool for <strong>method development</strong>, stability testing, and impurity profiling to ensure drug quality compliance with ICH guidelines.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used as analytical standards in HPLC and LC-MS systems for identifying and quantifying trace impurities in bulk drugs.</li>
<li><strong>R&D:</strong> Employed in stability-indicating method validation to monitor degradation products under various stress conditions.</li>
<li><strong>Regulatory Compliance:</strong> Submitted to regulatory agencies (FDA/EMA) to demonstrate control over specific genotoxic or toxicological impurities.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store in a cool, dry place away from light to prevent degradation. Personnel must utilize appropriate <strong>PPE</strong> including gloves and respirators due to potential irritant properties. This substance is for research use only and is not intended for direct clinical administration or therapeutic application.</p>